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ABSTRACT   3 
 4 
Objective  5 
To systematically assess the reporting of sample size calculation in RCTs on rehabilitation 6 
interventions for mechanical low-back pain (mLBP).  7 
 8 
Study selection  9 
We conducted an electronic database search for RCTs published from 1968 through February 2015 10 
and included in Cochrane Systematic Reviews (SRs). 11 
 12 
Data extraction  13 
Two investigators independently applied an ad hoc six-item checklist derived from the CONSORT 14 
2010 statement recommendations to extract data on sample size calculation. Primary outcome was the 15 
proportion of RCTs that reported sample size calculation; secondary outcome was the completeness of 16 
sample size analysis reporting. We also evaluated reporting’ improvement over time. 17 
 18 
Data synthesis 19 
Sample size calculation was reported in 80 (36.0%) of the 222 eligible RCTs included in 14 Cochrane 20 
SRs.  Only 13 (16.3%) of these RCT reports gave a complete description and about half reported four 21 
or more of the six elements of sample size calculation (median=4, IQR 3–5). Completeness of 22 
reporting sample size calculation improved from 1968 to 2013; beginning in 2005, the number of 23 
RCT reports containing this information increased over those not reporting it.  24 
 25 
Conclusions 26 
Despite improvement, reporting of sample size calculation and power analysis remains inadequate, 27 
limiting the reader’s ability to assess the quality and accuracy of rehabilitation studies.  28 
 29 
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 31 
 32 
Abbreviations 33 
RCT, randomized controlled trial  34 
CONSORT, Consolidated Standards of Reporting Trials  35 
 36 
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1. INTRODUCTION   37 
 38 
Well-designed, properly executed RCTs provide the most reliable evidence on the effectiveness of 39 
health care interventions 1. The validity of an RCT depends on several key factors that should be 40 
adequately reported: the sample size calculation is one of them. Sample size is related to statistical 41 
power, which derives from beta error or type II error 2,3: it represents the likelihood of failure to reject 42 
the null hypothesis when, in fact, it should be rejected. The investigator’s aim is to minimize this type 43 
of error by increasing the sample size. Sample size calculation is essential in study design because a 44 
low-powered study may fail to yield significant results and detect relevant clinical effects. Its 45 
description is fundamental in any published report so that readers can base their assessment on what is 46 
reported rather than rely on assumptions about how the study authors arrived at their results. 47 
However, sample size calculation is not always adequately reported 4-6.   48 
In order to ensure quality in trial conduction, the Consolidated Standards of Reporting Trials 49 
(CONSORT) 2010  statement recommends that authors provide a clear description of sample size 50 
calculation methods and assumptions as  follows: the estimated outcomes in each group (minimum 51 
important treatment effect or effect size), the level of significance (alpha or type I error), the statistical 52 
power (beta or type II error), and, for continuous outcomes, the assumed standard deviation of the 53 
measurements 4,7,8. In addition, the CONSORT guidelines also recommend reporting the primary 54 
outcome on which important differences between two groups are determined. Authors should 55 
therefore decide and state a priori the fixed values for parameter assumptions. Although the number of 56 
reports of RCTs in rehabilitation has been increasing 9, the majority of studies are based on clinical 57 
observations with small sample sizes and inadequate reporting of essential information 10.  58 
The purpose of the present review is to systematically assess the quality of reporting of power and 59 
sample size calculation in RCTs comparing mechanical low-back pain rehabilitation interventions and 60 
included in Cochrane systematic reviews. 61 
 62 
 63 
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2. METHODS  64 
 65 
2.1 Search strategy and study selection  66 
We conducted an electronic database search for systematic reviews published between 1968 and 67 
February 2015 limited to The Cochrane Database for Systematic Reviews. Search terms ‘back pain’ 68 
and ‘rehabilitation’ were run in “title,abstract,keywords” search tab in advance search strategy. We 69 
included a systematic review if the title or the abstract presented mechanical low-back pain as the 70 
disease target and the intervention was rehabilitative, as defined by the National Library of Medicine 71 
11
. We did not take into account interventions other than therapeutic rehabilitation (e.g., prevention) or 72 
involving population subgroups (e.g., pregnancy). From the eligible systematic reviews, we extracted 73 
all included trials with a randomized study design and published in English, Italian, Spanish or 74 
French. After removing duplicates of RCTs, two researchers (GC, SG) independently screened the 75 
title and abstract of all potentially eligible RCTs. Disagreements were resolved by consensus. 76 
 77 
2.2 Data Extraction  78 
We extracted the general characteristics of RCTs: year of publication, number of authors, first author’s 79 
geographic region (Europe, North and South America, Asia and Australia), journal that published the 80 
study, and funding source. We developed an ad hoc checklist derived from the CONSORT checklist to 81 
extract data on sample size calculation. The checklist was upload on Distiller SR, a web-based 82 
database for data management.  83 
We examined whether the RCT report included a power analysis in the Methods section and, if so, 84 
whether the description of the sample size calculation was CONSORT-compliant. Following the 85 
CONSORT checklist 7, we assessed the description for reporting of six sample size calculation 86 
components: (1) type I error, or alpha, (2) type II error, beta, or power, (3) assumption of expected 87 
treatment effect of the intervention (i.e., the difference between group means as effect size or minimal 88 
important difference and relative risk), and (4) the assumed variability expressed as a standard 89 
deviation or a variance or an intraclass correlation coefficient. We also looked for (5) the outcome on 90 
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which sample size calculation was based, and (6) whether there was an adjustment to accommodate 91 
attrition rate. In addition, we extracted from the Methods section the sample size planned (i.e. as 92 
resulted from the sample size calculation procedure) and from the Results section the actual number 93 
of participants randomized (N) according to the CONSORT flow diagram. If there was no statement 94 
or CONSORT flow diagram reporting the number of patients randomized, we extracted it from 95 
implicit information (i.e., “enrolled” or “included”). When articles reported the sample size 96 
calculation, we examined whether there was a discrepancy between the planned sample size and the 97 
number of participants randomized. Moreover, we asked whether sample size reporting might be 98 
influenced by the funding status of the RCT.  99 
Data extraction was independently performed by two reviewers (GC, SG). Disagreements were 100 
reconciled via consensus. 101 
 102 
2.3 Statistical Methods  103 
Descriptive statistics are presented as medians and interquartile ranges (IQR), or percentages when 104 
appropriate. The non-parametric matched-pairs Wilcoxon signed-rank test, and the Chi-squared test, 105 
were used for the statistical evaluations. For hypothesis testing, a probability level lower than 0.05 106 
was considered to be statistically significant. All statistical tests were two-sided. Stata software was 107 
used for all statistical analyses (Stata Corp., College Station, TX, USA).  108 
 109 
 110 
3. RESULTS 111 
 112 
3.1 Study selection 113 
We identified 14 relevant Cochrane systematic reviews in the Cochrane Library 12-25. Sixty out of 301 114 
RCTs included in these 14 systematic reviews were excluded because they were duplicates or multiple 115 
publications of the same RCT, 7 were excluded as their full text could not be retrieved, and 12 were 116 
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excluded because they did not satisfy the language criterion. A final total of 222 RCTs was included in 117 
our review. Figure 1. 118 
 119 
3.2 General characteristics  120 
The 222 eligible RCT reports were published in 78 journals. Most were published in Spine (22.5%, 121 
n=50), followed by Journal of Manipulative and Physiological Therapeutics (4.5%, n=10) Pain, 122 
British Medical Journal, and Archives of Physical Medicine and Rehabilitation (4.1%, n=9), and 123 
Clinical Journal of Pain (3.6%, n=8).  124 
Some 32 countries were indicated as the country of publication, with the three top countries being the 125 
United States (18.9%, n=42), the United Kingdom (13.1%, n=29) and the Netherlands (9.9%, n=22); 126 
most studies were published (59.5%, n=132) by European researchers. The period of RCTs 127 
publication was from 1968 to 2013. The characteristics of the RCTs are reported in Table 1.   128 
 129 
3.3 Sample size calculation 130 
3.3.1 Reporting  131 
Only 80 (36.0%) of the 222 RCTs reported sample size calculation. However, there was a significant 132 
improvement of sample size calculation reporting over time Figure 2. We found that 13.3% (11 of 83) 133 
of trials published on or before 1996 reported sample size calculation compared to 49.6% (69 of 139) 134 
of trials published on or after 1997 (Chi-squared=29.85, d.f.=1, p<0.001). Furthermore, we found an 135 
association between reporting of a funding source and sample size calculation reporting. In particular, 136 
48.8% (61 of 125) of the trials reporting a funding source were also reporting a sample size 137 
calculation compared to only 19.6% (19 of 97) of the trials not reporting a funding source (Chi-138 
squared=20.22, d.f.=1, p<0.001). This association was very strong in the post-CONSORT era with 139 
61.4% (54 of 88) of the trials reporting a funding source also reporting a sample size calculation vs. 140 
29.4% (15 of 51) of the RCTs not reporting a funding source (Chi-squared=13.19, d.f.=1, p<0.001). 141 
However, it was not significant in the pre-CONSORT era (18.9% vs. 8.7%, Chi-squared=1.86, d.f.=1, 142 
p=0.17); but data were scarce.  143 
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 144 
3.3.2 Complete description of sample size calculation 145 
Thirteen (16.3%) of the 80 RCTs reporting sample size calculation gave an adequate description of 146 
the a priori sample size calculation, with all six elements provided in compliance with CONSORT 147 
guidelines. Half of the RCTs reported at least four out of six elements. Figure 3.  148 
Of the six CONSORT components required for sample size calculation, the three most frequently 149 
reported were the power (91.3%, n=73), followed by the assumption concerning the expected 150 
treatment effect of the intervention (86.3%, n=69), and the alpha error or type I error (85.0%, n=68). 151 
Adjustment to accommodate attrition was the least frequently reported element (32.5%, n=26).  152 
 153 
3.3.3 Characteristics of each element reported 154 
Each element could be expressed in a different way; common expressions for elements are presented 155 
in Table 2. Power was usually defined as 1 – β (82.5%, n=66). The minimal important difference 156 
(MID) was the assumed value for the detection of treatment effect most often reported in the 80 trials 157 
(46.3%, n=37). Concerning the outcome on which the calculation was based, all RCTs evaluated 158 
continuous outcomes: disability was the one most often reported (42.5%, n=34), followed by pain 159 
(22.5%, n=18).  160 
 161 
3.4 Discrepancy between planned and randomized sample size 162 
Planned sample size was reported in 72 out of 80 RCTs. In the remaining 8 RCTs (10.0%) that 163 
reported the sample size calculation, the planned number of participants was not stated. The median 164 
number of participants needed to prove sufficient power was 120 (range: 17–2000), whereas the 165 
median of the number of participants randomized among these 72 RCTs was 133 (range: 21–741).  166 
The number of participants randomized was lower than the number of those planned in 17 RCTs 167 
(23.6%), equal in 13 (18.0%), and higher in 42 (58.4%); Figure 4 showed the discrepancy between 168 
sample size planned and the number of randomized participants when the number obtained by the 169 
sample size calculation increased.  170 
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 171 
4. DISCUSSION  172 
Reporting of sample size calculation in RCTs on low-back pain rehabilitation is often incomplete. We 173 
found that numerous RCTs published between the 1960s and the present failed to report a priori 174 
sample size calculation, barring readers from understanding whether calculation was done and 175 
whether done correctly. Among the RCTs reporting a priori sample size calculation, only a minority 176 
gave a complete description of the elements used. Nevertheless, the reporting of sample size 177 
calculation and its components has increased over years; since 2005 more RCTs report sample size 178 
calculation than those that do not.  Moreover, our results showed that the publication of the 179 
CONSORT statement has increased authors’ awareness of high quality reporting compared to the pre-180 
CONSORT era. Despite this, assessing the quality of the reporting does not necessary reflect the 181 
quality of the underlying research: it is fundamental distinguishing between ‘what researchers do’ and 182 
‘what researchers report’. For instance, the assessment of risk of bias in a RCT arises ambiguity 183 
between the quality of reporting and the quality of the research 26.  184 
Our findings are consistent with a previous review of the general medical literature that described 185 
poor compliance by authors with CONSORT guidelines. Similarly, a review of physical medicine and 186 
rehabilitation trials published between 1998 and 2008 found that reporting had improved somewhat, 187 
with only slightly more than half of the articles (57.3%) published in 2008 reporting sample size 188 
analysis 10. 189 
Conducting responsible research entails complete, accurate reporting in a transparent fashion 190 
according to international guidelines. To ensure high quality in conducting a clinical trial, it is not 191 
sufficient to state the sample size without giving a description of how it was calculated. More than 192 
half of the RCTs with a priori sample size analysis included in our review reported fewer than four of 193 
the six elements required for replication of calculations. A recent review (ACTTION Systematic 194 
Review) found that half of the published analgesic clinical trials gave an incomplete description of 195 
sample size calculation 2.   196 
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Sample size calculation is usually based on a single outcome, chosen as a primary measure: 197 
specifying it helps researchers to clarify the initial basis upon which an RCT is built, besides 198 
simplifying interpretation, judgment, and use of findings 27. We noted that more than half of the RCTs 199 
stated the primary endpoint, similar to the rates reported in a previous review in physical medicine 200 
trials 10. In the literature, disability and pain are the most frequently investigated outcomes in low-201 
back pain rehabilitation: several authors have recommended including these measurements in the 202 
back-specific core outcome sets because they are most relevant to patients, health care practitioners, 203 
regulators, industry representatives, and policy-makers 28. They were also the elective outcome 204 
measures most often used in RCTs according to our and a recent review which found a low frequency 205 
of reporting outcome and intervention descriptions, reflecting a multidimensional lack of quality in 206 
rehabilitation RCTs 29. 207 
Among the RCTs in which a power analysis was performed, 72 reported the planned sample size. In 208 
two out of three of these RCTs the randomized sample size was larger than that planned, and in a 209 
small proportion (30%) the randomized sample size was smaller than that planned. While authors are 210 
always encouraged to include more than the minimum number of participants to compensate for loss 211 
to follow-up, overrecruitment to account for attrition is unjustifiable both economically and ethically 212 
– economically unsound because of the high costs of clinical trials and ethically questionable because 213 
of potential harm to patients. Except for trials on rare diseases or early-phase trials, underpowered 214 
studies are unethical because they may fail to yield significant results, are more likely to be 215 
inconclusive and produce more false negatives 1,30,31. However, trials with an overly large sample size 216 
may waste resources in terms of patients, time and funding. Authors should aim to achieve robust 217 
research findings by calculating an adequate sample size, using time and resources in the best cost-218 
effective manner 32 and in collaboration with experienced biostatisticians and methodologist-219 
researchers 33.  220 
Our results show that funding status influences the quality of reporting. Building a sustainable funding 221 
scheme for clinical comparative research in areas less explored, i.e., the “orphan areas” such as 222 
anesthesiology or orthopedics, is critical to support evidence-based practice in medical research 34. 223 
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Funding is fundamental to obtaining more resources in terms of personnel and to make the research 224 
process more efficient. Economic support is important in both pharmacological research and research 225 
areas where public health needs are changing. For example, rehabilitation for low-back pain has 226 
increased its importance in both primary care, where rehabilitation as intervention plays a central role 227 
in LBP management, and research 9; therefore, evidence-based rehabilitation has grown. When the 228 
aim is to translate results from research to practice, it is essential to focus on how the evidence is 229 
generated: the quality of RCTs can directly influence the conclusions of systematic reviews, with the 230 
risk that trials failing to detect a real difference between treatment effects may inflate the results of 231 
meta-analyses, obfuscating the decision-making process of physical therapists. RCT reports should 232 
provide essential information so that readers can make better decisions in clinical practice, especially 233 
in the rehabilitation of low-back pain, an increasingly common health problem with a substantial 234 
community and financial burden 35,36.  235 
Future studies should assessed the quality of reporting of other essential elements for clinicians in 236 
rehabilitation. For instance, an adequate and satisfied description of the experimental intervention 237 
should be crucial, as well as the description of the target population and the outcomes selection. 238 
Maybe a multidimensional lack of reporting of information exists, reflecting difficulties in 239 
transferring the research’s results in clinical practice. 240 
 241 
4.1 Study Limitations  242 
This study focused only on the reporting of sample size calculation and its components as described in 243 
the Methods section of RCTs. It would have been interesting to compare the final publication with the 244 
published protocol in order to explore whether the absence of some elements was limited to the 245 
research article or were included in the research protocol. This was not possible because our sample 246 
comprised a wide range of RCTs published from 1968 to 2013.   247 
248 
5. CONCLUSION 249 
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Sample size calculation is essential to demonstrate that a trial is adequately designed to detect a likely 250 
real effect or association, if such exists, in a given population 32. Although some elements are difficult 251 
to define, the assumptions made in the calculation should be reported in a transparent fashion. The 252 
CONSORT statement provide a standard guidance for authors to prepare reports of trial findings and 253 
to facilitating their complete and transparent reporting. As well, the SPIRIT (Standard Protocol Items 254 
Recommendation for Interventional Trials) initiative recently has strengthened the purpose to improve 255 
transparency in the trial protocols 37. Furthermore, Cook et al. have just created a more extensive set 256 
of elements for adequate reporting of this process in trial protocols and results, providing also 257 
justifications for sample size calculation’ assumption 27. Just as researchers should be encouraged to 258 
use these guidelines so, too, journal editors and peer reviewers should impose stricter criteria for 259 
adequate and transparent reporting. In addition, the sharing of software could help to simplify sample 260 
size calculation. Improving the methodological quality of RCTs, and all types of trials, will go some 261 
way to ensure the validity of results, reproducibility of research, and dissemination of results from 262 
research to practice.  263 
 264 
 265 
 266 
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Figure legend list 401 
Figure 1. Flow diagram. 402 
Figure 2. Trend for improvement in reporting of sample size calculation over time. 403 
Figure 3. Completeness of sample size calculation description. 404 
Figure 4. Discrepancy between the sample size planned and the sample size randomized. 405 
Table 1. General characteristics of the RCTs. 406 
Table 2. Commonly reported elements for sample size calculation. 407 
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 Frequency (No.) (%) 
No. of countries  32   
USA 42 18.9 
UK 29 13.1 
The Netherlands  22 9.9 
Norway 15 6.8 
Sweden 14 6.3 
Finland 12 5.4 
Australia 10 4.5 
Canada  10 4.5 
Turkey 10 4.5 
No. of journals  78   
Most frequent journals     
Spine 50 22.5 
Journal of Manipulative and Physiological Therapeutics 10 4.5 
Pain; British Medical Journal; Archives of Physical 
Medicine and Rehabilitation 9 4.1 
Clinical Journal of Pain 8 3.6 
No funding reported, no. (%) 97 43.7 
 median Range 
No. of authors, median (IQR)  5 1-12 
Year of publication of trial report, median (IQR) 2000 1968-2013 
 
Table 1. General characteristics of the RCTs.  
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Table 2. Commonly reported elements for sample size calculation. 
 
Sample size calculation elements No. (%) 
Level of significance  
Alpha (type I error) 68 (85) 
Power  
Beta (type II error) 10 (12.5) 
1 - Beta  66 (82.5) 
Total 73 (91.3) 
Assumption for treatment effect   
MID* 37 (46.3) 
Effect Size 9 (11.3) 
Other (i.e., reduction in %) 24 (30) 
Total 69 (86.3) 
Assumption for variability  
Standard deviation 28 (35) 
Other (i.e., variance) 7 (8.8) 
Total 35 (43.8) 
Correction for losses to follow-up 26 (32.5) 
Outcome considered for sample calculation   
Disability 34 (42.5) 
Pain 18 (22.5) 
Other (i.e., recovery rate, work days) 19 (23.8) 
Total  63 (78.8) 
*MID denotes minimal important difference 
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Key findings 
Numerous RCTs on rehabilitation interventions for mechanical low-back pain, published between the 1960s 
and the present, failed to report a priori sample size calculation, describing a poor adherence to the 
CONSORT statement recommendations.  
 
What this adds to what was known 
This is the first article that evaluate sample size reporting for each of the CONSORT 2010 recommended 
descriptive elements in RCTs on low back pain’s rehabilitation.  
Low-back pain is an increasingly common health problem with a substantial socio-economic burden: despite 
the call for evidence-based interventions, a lack of methodological quality in rehabilitation RCTs exists.  
 
What is the implication, what should change now 
To ensure high quality in conducting a clinical trial, researchers should be mostly encouraged to use 
international guidelines whereas journal editors and peer reviewers should impose stricter criteria for 
adequate and transparent reporting. 
 
